发布时间:
2020
-
08
-
06
点击次数:
0
Positions：
Business Development Vice President
Company：
Akeso,Inc.(9926.HK)
个人简介：
Dr. Michael Chen has dedicated himself to biopharmaceutical industry and global business development for years and has extensive experience and practical achievements in external innovation, pipeline cooperation and business development. Before joining Akeso, Dr. Chen worked as Head of External Innovation APAC for Merck KGaA. Dr. Chen led collaborations with local pharmaceutical/biotech companies, investor groups and academic institutions in China and APAC areas. Meanwhile, Dr. Chen was also responsible for the international business development department of Merck in China and APAC areas, carrying out a variety of internal and external business cooperation. This particularly involved opportunity finding and leading discussions through various approaches, including open innovation, licensing, co-development, investment, and other collaboration models. Dr. Chen was also one of the leading members of Merck Asia and China research and development center, from which he worked along with R&D team for Merck’s own pipeline in regional development, and alliance management of external collaborations. Dr. Chen was also one of the core members for expanding Merck’s oncology business and innovation collaboration in China. Dr. Chen received his bachelor’s degree of cell and molecular biology from University of Essex, a master’s degree in cancer immunotherapy from University of Nottingham and a Ph.D. degree in biochemistry from Imperial College London. Before joining Merck, he has been leading research projects in the UK at Spirogen Ltd, later acquired by MedImmune, LLC (a company of AstraZeneca PLC). He then returned to China and led business development and investment activities at WuXi Biologics and ChemPartner.